The pituitary gonadotrophins, LH and FSH, are heterodimeric molecules comprising a common α-subunit and a hormonespecific β-subunit. LH and FSH are synthesized in and secreted from gonadotroph cells situated in the anterior pituitary gland. Their action is synergistic and pivotal for puberty and subsequent fertility. Gonadotrophin-releasing hormone (GnRH) is released from the hypothalamus and binds to the GnRH receptor (GnRHr) on the gonadotroph cell surface to stimulate the synthesis and release of LH and FSH. In turn, LH and FSH act on the ovary and testes to stimulate spermatogenesis, folliculogenesis and, in females, LH triggers ovulation. The synthesis and secretion of LH and FSH are both positively and negatively regulated by steroids and gonadal peptides (Fig. 1) . Investigation of the transcription factors and cognate DNA elements required to activate and direct expression of gonadotrophin subunit genes is currently an active area of research.
Transcriptional regulation of the gonadotrophin subunits involves two key overlaying mechanisms. First, basal gene expression is activated in and targeted to gonadotroph cells and is maintained throughout development. Second, as GnRH secretion increases, basal gonadotrophin gene expression is upregulated, reaching maximum adult values at puberty. Blocking GnRH input returns gonadotrophin gene expression to basal levels (McNeilly et al., 1991) . Therefore, it appears that some transcription factors regulate basal tissuespecific gene expression, and some regulate GnRH upregulation of gene expression. Synergism between the two types of transcription factor ensures gonadotroph-specific GnRH-regulatable gene expression. However, it must be stressed that it has not been established unequivocally that transcription factors that control basal gene expression are not regulated by GnRH, and vice versa, but for the purposes of this review they have been arbitrarily classified into two groups: basal and GnRH-regulated transcription factors. It has also not been established whether there is a basal or GnRHregulated transcription factor that directs gonadotroph-specific gene expression and specifies the gonadotroph cell type. However, there is evidence that transcriptional regulation of the expression of the LH β-subunit gene is sexually dimorphic, to allow the generation of the preovulatory LH surge in females.
Basal gonadotrophin subunit gene expression

Targeting and activation of gonadotroph-specific gene expression
A controlled cascade of spatially and temporally regulated transcription factors initiates and maintains the basal expression of gonadotrophin genes during embryogenesis (Figs 2 and 3a) . This cascade involves multiple signalling pathways that control transcription factor expression and, thus, are responsible for gonadotroph differentiation (Treier et al., 1998) . The gonadotroph cell lineage originates in the ventral part of the embryonic pituitary and is characterized initially by the expression of α-subunit transcripts and, after a further 6 days, by the expression of LH and FSH β-subunit transcripts (Japon et al., 1994) . Transcription factors that activate gonadotrophin α-and β-subunit gene transcription are expressed during this developmental window (Table 1) . It should be noted that most of these transcription factors specify other pituitary cell lineages in addition to gonadotrophs (for review, see WatkinsChow and Camper, 1998) .
Pituitary homeobox 1 (Ptx1) is expressed in several anterior pituitary cell lineages and transactivates most of the anterior pituitary cell-specific genes, including the α-subunit, LH and FSH β-subunit genes (Tremblay et al., 1998) . Hesx1-Rpx expression is restricted to Rathke's pouch during pituitary development (Hermesz et al., 1996) , and the 'knock-out' phenotype indicates that it is involved in cellular expansion of the pituitary before differentiation (Dattani et al., 1998) . Studies in vitro indicate that Hesx1-Rpx transactivates LH β-subunit gene expression (Brown et al., 1999) . The pLIM-Lhx3 homeobox gene specifies several pituitary cell lineages (Sheng et al., 1996) and transactivates gonadotrophic α-subunit gene expression (Bach et al., 1995) . Steroidogenic factor 1 (SF-1) is specifically found in the gonadotroph cell lineage of anterior pituitary cells, but it is also expressed in other non-pituitary tissues, including the adrenals and gonads (Luo et al., 1994) . SF-1 stimulates α-subunit (Horn et al., 1992; Barnhart and Mellon, 1996) and LH β-subunit gene expression (Halvorson et al., 1996; Keri and Nilson, 1996) , but does not activate FSH β-subunit gene expression (Tremblay et al., 1998) . However, SF-1 does not specify the gonadotroph cell lineage because, although SF-1 'knock-out' mice do not express LH and FSH β-subunit genes, they still have viable gonadotroph cells, and the expression of LH and FSH β-subunit genes are induced when these mice are treated with GnRH (Ikeda et al., 1995) . Otx1 transcription factor 'knock-out' mice exhibit the very unusual phenotype of transient dwarfism and hypogonadism (Acampora et al., 1998) . Essentially, gonadotroph cells are intact, as in SF-1 'knock-out' mice, but prepubertal expression of gonadotrophins is impaired, only recovering after puberty.
It has not been determined whether there is a pivotal transcription factor that specifies the gonadotroph cell type and activates transcription of all the gonadotrophin subunits. Detailed analysis of the defined DNA elements in the mouse α-subunit promoter reveal that the -337 to -330 bp element, the pituitary glycoprotein hormone basal element (PGBE), binds a LIM-homeodomain transcription factor (LH-2; Roberson et al., 1994) and is required for basal α-subunit gene expression. A transgenic mouse model confirmed that the PGBE was required to direct gonadotroph-specific expression (Brinkmeier et al., 1998) . However, the PGBE is also transactivated by p-Lim-Lhx3 (Bach et al., 1995) , which specifies multiple anterior pituitary cell lineages (Sheng et al., 1996) .
Although SF-1 stimulates α-subunit and LH β-subunit gene expression, SF-1 gene expression is activated at embryonic day 13.5 (e13.5), after the activation of α-subunit gene expression on e10.5, while the earliest detectable LH β-subunit transcripts appear at e16.5 (Fig. 2 ). It appears that, after activation of α-subunit gene expression, undiscovered transcription factors suppress SF-1 and LH β-subunit gene activation in Gonadotrophin-releasing hormone (GnRH) synthesized in and released from the hypothalamus binds to GnRH receptor (GnRHr), a seven transmembrane G-protein-coupled receptor located on the surface of the gonadotroph. The binding of GnRH to the GnRHr triggers the synthesis, and ultimately the secretion, of LH and FSH into the vascular system. A stylized steroid receptor (SR) is also indicated on the gonadotroph cell, this represents androgen, oestrogen and progesterone receptor. Testosterone (T), oestrogen (E) and progesterone (P) negatively regulate gonadotrophin synthesis directly at the pituitary and via downregulation of hypothalamic GnRH secretion. The gonadal peptides, inhibin and activin, have opposing roles in regulating gonadotrophin synthesis and seem to regulate production of FSH. Activin transactivates its own receptor (activin receptor; ActR) but it is yet to be determined whether inhibin signals through the same or an unidentified receptor.
precursor gonadotrophs. Possible transcription factors that repress gene expression are the dominant negative helix-loophelix (Id) proteins that inhibit gene activation by basic helixloop-helix (bHLH) transcription factors. bHLH factors bind to E-boxes, which have a loose consensus sequence of CANNTG. This interaction of Id and bHLH mediated via E-boxes appears to be important for regulating expression of α-subunit in gonadotrophs (Jackson et al., 1995) . In addition, GATA factors (so-called because they bind to a central DNA consensus of GATA) may be involved in early pituitary specification of α-subunit gene expression since they transactivate gene expression in vitro (Steger et al., 1994) .
Upregulation of basal gene expression
GnRH modulation of gonadotrophin gene expression
The acquisition of GnRH responsiveness is dependent on the activation of intracellular signalling transduction pathways stimulated by the binding of GnRH to the GnRHr (Fig. 3b) . The GnRHr is a G-protein-coupled seven transmembrane receptor that signals predominantly via the protein kinase C (PKC) pathway (for review, see Anderson 1996) . This stimulatory signal is relayed to the nucleus via transcription factors that bind to discrete DNA sequences on the gonadotrophin subunit promoters and, thus, transactivate gene expression. After gonadotrophin subunit gene expression has been activated during embryogenesis, basal expression gradually increases in response to non-pulsatile secretion of GnRH. Activation of the GnRH pulse generator occurs at the onset of puberty and results in increased GnRH release which, in turn, stimulates gonadotrophin subunit gene expression. This dual control of gonadotrophin subunit gene expression is demonstrated in hypogonadal mice, which never progress through puberty because of a mutation in the GnRH gene. These mice have functional gonadotrophs and basal gonadotrophin subunit gene expression, which is upregulated after the administration of GnRH (Cattanach et al., 1977) . This observation confirms that GnRH upregulates basal gonadotrophin gene expression.
GnRH regulation of common α-subunit gene expression
GnRH-responsive regions have been mapped in the α-subunit promoter of several species. In humans, cows and mice, the DNA elements that confer GnRH responsiveness all reside in the proximal promoter: human -346 to -244 (Kay and Jameson, 1992), cow -315 (Hamernik et al., 1992) and mouse -406 to -399 and -337 to -330 bp (Schoderbeck et al., 1993) . The -337 to -330 bp site in the mouse α-subunit promoter binds a LIM homeodomain transcription factor that directs basal expression and has already been discussed. The second identified site at -406 to -399 binds a factor that was stimulated by GnRH via the mitogen-activated protein kinase pathway (MAPK) (Roberson et al., 1995) . Synergism of the transcription factors that bind to Rathke's pouch is formed from the hypophyseal placode of oral ectoderm that invaginates at approximately embryonic day 9.5 (e9.5). Cell proliferation then occurs in the anterior pituitary before pituitary cell-specific genes can be identified. The earliest identifiable marker of pituitary gene expression is the common α-subunit, which is activated at e10.5, a full 6 days before LH β-subunit (e16.5) and FSH β-subunit (e17.5) gene expression is detected. NE: neuroectoderm.
these two DNA sites in the α-subunit promoter is required to activate GnRH regulation of gene expression. Cyclic AMP (cAMP) responsive elements (CRE) have been identified in the human α-subunit promoter, but not in that of other species, at -132 to -99 bp (Schroderbeck et al., 1992) . Although this element is critical for placental expression of the α-subunit, originally it was not thought to be important for pituitary expression. However, Saunders et al. (1998) have shown that cAMP stimulates α-subunit transcription, and that this is additive to the stimulation mediated by the PKC pathway, although it is unclear whether this is mediated via a CRE. GnRHr signalling also increases α-subunit transcription by mobilizing extracellular calcium, and the DNA elements responsible map to between -420 and -244 bp in the human α-subunit promoter (Holdstock et al., 1996) . This finding has been confirmed in some studies (Saunders et al., 1998) but not in others (Weck et al., 1998) . Differences in the intracellular signalling of the GnRHr mediated by PKC-and cAMP-activated pathways, and by calcium influx, may be part of the mechanism that ensures adequate amounts of α-subunit are synthesized in different physiological states (Fig 3) , especially since α-subunit is always synthesized in excess over the β-subunits. 
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GnRHr GnRHr G protein et al., 1998) ; GATA: binds to GATA DNA consensus (Steger et al., 1994) ; SF-1: steroidogenic factor 1 (Horn et al., 1992; Barnhart and Mellon, 1996; Halvorson et al., 1996 Halvorson et al., , 1998 Keri and Nilson, 1996) ; p-LIM: LIM homeobox gene (Bach et al., 1995) ; LH-2: LIM homeobox gene (Roberson et al., 1994) ; Ets (Roberson et al., 1995) ; NGFI-A: nerve growth factor 1A (Lee et al., 1996; Halvorson et al., 1999) ; SP-1 (Kaiser et al., 1998); AP-1: activating protein 1 (Strahl et al., 1998) . Interactions between basal and GnRH-regulated transcription factors are as follows: SF-1 synergises with NGFI-A ( Lee et al., 1996; Halvorson et al., 1998) ; LH-2 synergises with Ets (Roberson et al., 1994) ; GnRH regulates SP-1 (Kaiser et al., 1998b) , NGFI-A (Halvorson et al., 1999) , Ets (Roberson et al., 1995) and AP-1 (Strahl et al., 1998) . Extracellular Ca 2+ influx upregulates unknown factor x, which transactivates α-subunit and LH β-subunit promoters (Holdstock et al., 1996; Weck et al., 1998) . PLC: phopholipase C; IP 3 : inositol 1,4,5 triphosphate; DAG: diacylglycerol; PKC: protein kinase C; MEK: mitogen-activated protein kinase kinase or MAPKK; MAPK: mitogen-activated protein kinase.
GnRH regulation of LH β-subunit gene expression
LH β-subunit promoter elements required to mediate GnRH-responsiveness have been found in -1786 bp of the sheep promoter (Brown et al., 1993; McNeilly et al., 1996) and -2000 bp of the rat promoter (Fallest et al., 1995) and have been further localized to -776 bp in the cow promoter (Keri et al., 1994) . Studies in vitro on the regulation of LH β-subunit gene expression by GnRH have been hampered by the lack of suitable cell lines that express the LH β-subunit. The isolation of the LH-expressing gonadotroph cell line, LβT2 (Thomas et al., 1996) , will provide a model system to investigate control of LH β-subunit gene expression. LβT2 cells synthesize and secrete LH in response to GnRH stimulation (Turgeon et al., 1996) . GnRH responsiveness has been mapped to a region upstream of -650 bp in the sheep LH β-subunit gene promoter using LβT2 cells (P. Brown, unpublished) .
LH β-subunit transcriptional stimulation by GnRH is mediated by stimulation of the PKC pathway (Saunders et al., 1998) and, to a lesser extent, by stimulation of the MAPK pathway (Weck et al., 1998) and cAMP pathway (Saunders et al., 1998) . Mobilization of extracellular calcium did not increase transcription in one study (Saunders et al., 1998) , but significantly increased it in another (Weck et al., 1998) . These differences may be due to the cell types used for the studies. Two regions have been identified in the rat LH β-subunit promoter that mediate GnRH stimulation of transcription: at -490 to -352 and -207 to -82 bp (Kaiser et al., 1998a) . The -490 to -352 region binds the ubiquitous transcription factor, Sp-1 (Kaiser et al., 1998b) .
Transcription factors, which are widely expressed in a number of tissues, have a role in stimulating LH β-subunit transcription (Fig. 3b) . A nerve growth factor 1A (NGF1-A) 'knock-out' mouse model had an unusual phenotype, with sterile females and fertile males. The females did not express the LH β-subunit gene and their ovaries had no corpora lutea, indicating the absence of ovulation (Lee et al., 1996) . An NGF1-A-binding site in the LH β-subunit promoter is located approximately 10-15 bp upstream of the TATA box. A second NGF1-A site has been identified upstream of this site at -112 bp (Halvorson et al., 1998) . The sexually dimorphic difference in the 'knock-out' phenotype prompted speculation that this transcription factor is required to facilitate the LH surge in females (Lee et al., 1996) , especially since NGF1-A gene expression is stimulated by GnRH (Halvorson et al., 1999) .
SF-1 also plays a role in the GnRH regulation of LH β-subunit gene expression. The SF-1 DNA binding site discovered in LH β-subunit promoters is highly conserved across species and occurs at approximately -130 bp. A second SF-1 site in the rat promoter at -59 bp is also conserved across species and synergises with the NGF1-A site at -112 bp (Halvorson et al., 1998) . The stimulatory ligand for SF-1 was thought initially to be GnRH (Haisenleder et al., 1996) , but this hypothesis has yet to be confirmed (Brown and McNeilly, 1997; Kaiser et al., 1998a; Halvorson et al., 1999) . The high degree of synergism between SF-1 and NGF1-A ( Lee et al., 1996; Halvorson et al., 1998) and the stimulation of NGF1-A by GnRH (Halvorson et al., 1999) illustrates the two-tier method of control of β-subunit gene expression. SF-1 directs basal LH β-subunit gene expression, which is synergistically augmented by GnRH-regulated transcription factors (Fig. 3) .
GnRH regulation of FSH β-subunit transcription
Experiments in vitro have defined the regions responsible for activation of FSH β-subunit gene expression to two activating protein 1 (AP-1) sites, which localized to -215 bp of the promoter at positions -120 and -83 bp (Strahl et al., 1997) . The AP-1 sites confer GnRH responsiveness (Strahl et al., 1998) and this is relayed by the PKC pathway (Strahl et al., 1998; Saunders et al., 1998; Fig. 3) . Calcium influx appears to have no major role in the regulation of FSH β-subunit gene expression (Saunders et al., 1998) .
Modulation of GnRH-regulated gene expression by gonadal steroids and peptides
Gonadotrophin gene expression is negatively regulated by feedback suppression of gonadal steroids that act at the pituitary and the hypothalamus to downregulate the GnRH pulse et al., 1998 generator. Positive feedback of steroids is required to generate the pre-ovulatory LH surge, but this is probably mediated at the level of LH secretion and not synthesis (Currie and McNeilly 1995; Thomas and Clarke, 1997) . The gonadal peptides, inhibin and activin, have antagonistic roles in modulating pituitary gonadotrophin gene expression (Fig. 1) . The α-and β-subunits show different degrees of response to feedback regulation.
Steroid-mediated repression of gene expression
α-Subunit. Administration of oestrogen in vivo profoundly downregulates α-subunit gene expression by a mechanism that is not mediated by receptor binding to the α-subunit promoter (Keri et al., 1991) . Similarly, the androgen receptor downregulates human α-subunit gene transcription by interfering with basal expression and with the CRE rather than through binding to the androgen receptor binding site (Heckert et al., 1997) .
LH β-subunit. Evidence for a direct inhibitory effect of steroids on LH β-subunit gene expression is weak or contradictory. It appears that there is no direct interaction of oestradiol receptor with the LH β-subunit promoter (Keri et al., 1994) , indicating that any inhibitory effects of steroids on LH β-subunit gene expression are not mediated via a classical oestrogen response element (ERE) on the LH β-subunit gene promoter. Studies in vitro, in which LβT2 cells were cultured with and without oestradiol, showed that oestradiol did not affect LH β-subunit mRNA concentrations, but did increase GnRHr mRNA concentrations (Turgeon et al., 1996) . This observation implies that steroids affect LH β-subunit synthesis by increasing GnRHr gene expression. In contrast, studies in vivo suggest that oestradiol negatively regulates LH β-subunit transcription by downregulating expression of SF-1 (Brown and McNeilly, 1997).
FSH β-subunit. FSH β-subunit gene transcription is highly sensitive to the negative feedback effects of steroids. Experiments using nuclear run-on assays demonstrate that oestradiol and progesterone downregulate FSH β-subunit gene transcription (Phillips et al., 1988) . Studies in vitro of the FSH β-subunit promoter localize the effect of oestrogen not to an ERE but to AP-1 sites, which also confer GnRH responsiveness (Miller and Miller, 1996; Strahl et al., 1998) .
Regulation of gonadotrophin subunit gene expression by inhibin and activin. Inhibin and activin are members of the transforming growth factor β (TGF-β) family of cytokines. The signal transduction pathway from the cell membrane to the nucleus used by TGF-β (Heldin et al., 1997) involves the activation of transcription from AP-1 binding sites (Zhang et al., 1998) . Activin upregulates FSH β-subunit gene expression (Weiss et al., 1995) and, since there are AP-1 binding sites on the FSH β-subunit promoter (Strahl et al., 1997) , these may be used to control FSH β-subunit transcription. Inhibin antagonizes the stimulatory effect of activin on FSH β-subunit gene expression, and this may be mediated by the same signalling pathways used by activin. Inhibin action downregulates transcription of the FSH β-subunit, but has no effect on the transcripton of the LH β-subunit (Clarke et al., 1993) . This signalling pathway may also converge on the AP-1 binding sites found in the proximal FSH β-subunit promoter.
Conclusions and future prospects
Transcription factors that control gonadotrophin gene expression can be classified into those that direct basal expression and those that are regulated by GnRH. This biphasic model of control of gonadotrophin gene expression assumes that basal gonadotroph-specific gene expression is further modulated by GnRH. The transcription factors known to direct basal gene expression do not specify the differentiation of the gonadotroph cell type. It is possible that there is no single transcription factor that, if 'knocked-out', would only remove gonadotroph cells or, alternatively, that the gonadotroph cell type may be specified by a multifactor complex. Transcription factors regulated by steroids or gonadal peptides also modulate gonadotrophin subunit gene expression by antagonizing or possibly augmenting the effects of GnRH-induced transcription factors. These effects of transcription factors all rely on either differential activation or crosstalk of intracellular signalling pathways. Since LH and FSH β-subunit genes are both expressed in the same cell type and are both regulated by GnRH, the number of GnRH receptors (Kaiser et al., 1995) and subsequent coupling to G-proteins (Stanislaus et al., 1998) could both contribute to differential coupling to intracellular signalling pathways. In addition, differential modulation by steroids and gonadal peptides also ensures that the two gonadotrophins are differentially synthesized. A future research challenge is to understand how differential activation of transcription factors is controlled to explain the in vivo regulation of gonadotrophin gene expression. An example is the differential regulation of LH and FSH gene expression across the female oestrous cycle that is necessary for their synergistic action and the perturbation of which profoundly affects reproductive function (P. Brown, J. R. McNeilly, J. G. Evans, H. C. Christian and A. S. McNeilly, unpublished) . Ultimately, regulatory signals are transduced into transcriptional activation or repression by interaction of transcription factors, with the specific transcription factor binding sites located on the gonadotrophin subunit gene promoters.
